Our Bureau

HYDERABAD: Natco Pharma Ltd has announced a tie-up with the US-based Temple University.

In a press release here on Tuesday, the company said the tie-up facilitates undertaking of specified biological studies by the university, for establishing the in vivo efficacy of some promising anti-cancer compounds useful in the treatment of chronic myeloid leukaemia (CML).

The company said it had, as a part of its research activities, identified, designed and synthesised, at its Research Centre (Natco Research Centre), certain potentially active anti-cancer compounds useful in the treatment of CML. It has already completed the in vitro studies of these compounds and found them been highly satisfactory.

Natco Pharma, with the active assistance of Temple University, seeks to complete the in vivo studies to establish the positive efficacy of the compounds by the end 2005.

© Copyright 2000 - 2009 The Hindu Business Line